Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junken Aoki

Showing results (221-230 of 368) with videos related to

Pageof 37
Sort By:
Journal of Medicinal Chemistry|March 6, 2020
Identification of Potent <i>In Vivo</i> Autotaxin Inhibitors that Bind to Both Hydrophobic Pockets and Channels in the Catalytic DomainMitsuyasu Kawaguchi, Takayoshi Okabe, Shinichi Okudaira, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 11, 2017
LPA<sub>1</sub> receptor-mediated thromboxane A<sub>2</sub> release is responsible for lysophosphatidic acid-induced vascular smooth muscle contractionPéter Tibor Dancs, Éva Ruisanchez, Andrea Balogh, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|March 9, 2019
LPA<sub>1</sub> , LPA<sub>2</sub> , LPA<sub>4</sub> , and LPA<sub>6</sub> receptor expression during mouse brain developmentOlga Suckau, Isabel Gross, Sandra Schrötter, et al.
Immunity|February 3, 2023
Direct activation of microglia by β-glucosylceramide causes phagocytosis of neurons that exacerbates Gaucher diseaseTakashi Shimizu, Charles R Schutt, Yoshihiro Izumi, et al.
Anticancer Research|March 10, 2015
Phosphatidylserine-specific phospholipase A1 (PS-PLA1) expression in colorectal cancer correlates with tumor invasion and hematogenous metastasisYuuki Iida, Eiji Sunami, Hiroharu Yamashita, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 30, 2024
Suppression of Mast Cell Activation by GPR35: GPR35 Is a Primary Target of Disodium CromoglycateMasumi Oka, Sohta Akaki, Osamu Ohno, et al.
The Tohoku Journal of Experimental Medicine|April 3, 2024
New Dihydropyridine Derivative Attenuates NF-κB Activation via Suppression of Calcium Influx in a Mouse BV-2 Microglial Cell LineKota Sato, Yuto Sasaki, Michiko Ohno-Oishi, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|July 30, 2019
Placental expression of lysophosphatidic acid receptors in normal pregnancy and preeclampsiaTatsuya Fujii, Takeshi Nagamatsu, Danny J Schust, et al.
Journal of Medicinal Chemistry|April 29, 2005
Structure-activity relationships of fluorinated lysophosphatidic acid analoguesYong Xu, Junken Aoki, Kumiko Shimizu, et al.
Biology of Reproduction|September 8, 2007
Embryo spacing and implantation timing are differentially regulated by LPA3-mediated lysophosphatidic acid signaling in miceKotaro Hama, Junken Aoki, Asuka Inoue, et al.
Pageof 37

Showing results (221-230 of 368) with videos related to

Sort By:
Pageof 37
Journal of Medicinal Chemistry|March 6, 2020
Identification of Potent <i>In Vivo</i> Autotaxin Inhibitors that Bind to Both Hydrophobic Pockets and Channels in the Catalytic DomainMitsuyasu Kawaguchi, Takayoshi Okabe, Shinichi Okudaira, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 11, 2017
LPA<sub>1</sub> receptor-mediated thromboxane A<sub>2</sub> release is responsible for lysophosphatidic acid-induced vascular smooth muscle contractionPéter Tibor Dancs, Éva Ruisanchez, Andrea Balogh, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|March 9, 2019
LPA<sub>1</sub> , LPA<sub>2</sub> , LPA<sub>4</sub> , and LPA<sub>6</sub> receptor expression during mouse brain developmentOlga Suckau, Isabel Gross, Sandra Schrötter, et al.
Immunity|February 3, 2023
Direct activation of microglia by β-glucosylceramide causes phagocytosis of neurons that exacerbates Gaucher diseaseTakashi Shimizu, Charles R Schutt, Yoshihiro Izumi, et al.
Anticancer Research|March 10, 2015
Phosphatidylserine-specific phospholipase A1 (PS-PLA1) expression in colorectal cancer correlates with tumor invasion and hematogenous metastasisYuuki Iida, Eiji Sunami, Hiroharu Yamashita, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 30, 2024
Suppression of Mast Cell Activation by GPR35: GPR35 Is a Primary Target of Disodium CromoglycateMasumi Oka, Sohta Akaki, Osamu Ohno, et al.
The Tohoku Journal of Experimental Medicine|April 3, 2024
New Dihydropyridine Derivative Attenuates NF-κB Activation via Suppression of Calcium Influx in a Mouse BV-2 Microglial Cell LineKota Sato, Yuto Sasaki, Michiko Ohno-Oishi, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|July 30, 2019
Placental expression of lysophosphatidic acid receptors in normal pregnancy and preeclampsiaTatsuya Fujii, Takeshi Nagamatsu, Danny J Schust, et al.
Journal of Medicinal Chemistry|April 29, 2005
Structure-activity relationships of fluorinated lysophosphatidic acid analoguesYong Xu, Junken Aoki, Kumiko Shimizu, et al.
Biology of Reproduction|September 8, 2007
Embryo spacing and implantation timing are differentially regulated by LPA3-mediated lysophosphatidic acid signaling in miceKotaro Hama, Junken Aoki, Asuka Inoue, et al.
Pageof 37